Category: U.S.

According to Novo Nordisk, the majority of U.S. patients who have insurance and use its widely sought-after weight loss medication, Wegovy, are spending under $25 per month for the treatment. (Photo: Novo Nordisk)
Estimated read time 4 min read
Health & Fitness U.S.

Access to Wegovy’s weight loss treatment improving for many insured Americans

  • Post Date 11/02/2023

Novo Nordisk, a global pharmaceutical company known for its innovative treatments in diabetes care and obesity management, recently announced an encouraging development regarding the accessibility [more…]

The CDC has issued a food safety alert for specific diced onion products from Gills Onions associated with the outbreak. The company issued a voluntarily recall. (Photo: FDA)
Estimated read time 2 min read
Health & Fitness U.S.

73 Salmonella cases across 22 states, CDC issues food safety alert

  • Post Date 10/26/2023

In a growing health crisis, a multistate salmonella outbreak has swept across 22 U.S. states, resulting in at least 73 reported cases and 15 hospitalizations, [more…]

At present, Arexvy has received approval for use in the United States, Europe, Japan, and various other countries, specifically for individuals aged 60 and above. (Photo: GSK)
Estimated read time 3 min read
Health & Fitness U.K. U.S.

GlaxoSmithKline’s Arexvy vaccine shows promise in protecting adults aged 50-59 against RSV

  • Post Date 10/25/2023

In a significant development, GlaxoSmithKline (GSK) announced promising results from a late-stage clinical trial for their vaccine, Arexvy, which exhibits the potential to protect adults [more…]

FILE - Pfizer, left, and Moderna bivalent COVID-19 vaccines are readied for use at a clinic, Nov. 17, 2022, in Richmond, Va. The Food and Drug Administration on Friday, June 16, 2023, told COVID-19 vaccine makers to update fall shots to target the latest omicron strain. (AP Photo/Steve Helber, File)
Estimated read time 4 min read
Health & Fitness U.S.

Individuals eager for Covid boosters are not receiving them as intended

  • Post Date 09/25/2023

The transition of responsibility for distributing Covid-19 vaccines from federal agencies to the commercial market has encountered significant challenges. Many individuals seeking Covid-19 booster shots [more…]

On September 19, Neuralink, revealed its recruitment drive for the inaugural human trial of a brain implant aimed at controlling movement. (Photo: Pavlo Gonchar | Sopa | Getty)
Estimated read time 3 min read
Health & Fitness U.S.

Neuralink poised to commence human trials for a brain implant designed to assist patients suffering from paralysis

  • Post Date 09/20/2023

Neuralink, the brain-implant startup led by Elon Musk, has announced that an independent review board has granted approval to initiate the recruitment of participants for [more…]